Trial NCT01313611

View at ClinicalTrials.gov 
Org. Study IDs: BRIEF

Last trial update was posted on 2018-03-07

MeSH Interventions

Bendamustine Hydrochloride Rituximab

MeSH Conditions

Lymphoma Lymphoma, Follicular

Other Conditions

Follicular Lymphoma

Stopping Reasons

Treament with rituximab during maintenance phase was stoped, according to DSMC recommendations, since 3 cases of deaths occured.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID